1
|
Yoshimura C, Murata J, Yamauchi A, Sunaga K, Kato M, Takigawa A, Nawa T, Akamatsu H, Kobayashi I, Tsujii M. [An anatomical case of obstructive jaundice due to the rapid enlargement of hepatic peribiliary cysts in end-stage alcoholic liver cirrhosis]. Nihon Shokakibyo Gakkai Zasshi 2023; 120:927-934. [PMID: 37952968 DOI: 10.11405/nisshoshi.120.927] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 11/14/2023]
Abstract
A man in his 60s had end-stage alcoholic cirrhosis. About six months before his death, hepatic peribiliary cysts (HPBC) rapidly increased, and he developed jaundice and liver failure. The pathological autopsy performed after his death revealed that his intrahepatic bile duct was pressured due to multiple cysts caused by HPBC, which resulted in liver failure. Some cases of HPBC have been associated with alcoholic cirrhosis;however, no other cases of increased HPBC in a short period of time have been reported. Although identifying the cause of increased HPBC in a short time is difficult in this case, it may be have been caused by continuous alcohol drinking after the onset of HPBC. Most patients with HPBC have liver cirrhosis and obstructive jaundice that may promote liver failure as in this case. Therefore, patients with HPBC should not only be instructed for abstinence but also promptly consider effective treatments in the event of obstructive jaundice to prevent liver dysfunction.
Collapse
Affiliation(s)
| | - Jun Murata
- Department of Gastroenterology, Higashiosaka City Medical Center
- Department of Gastroenterology, Ikeda City Hospital
| | - Amane Yamauchi
- Department of Pathology, Higashiosaka City Medical Center
| | - Koji Sunaga
- Department of Gastroenterology, Higashiosaka City Medical Center
| | - Mina Kato
- Department of Gastroenterology, Higashiosaka City Medical Center
| | - Atsuo Takigawa
- Department of Gastroenterology, Higashiosaka City Medical Center
| | - Takatoshi Nawa
- Department of Gastroenterology, Higashiosaka City Medical Center
| | - Haruki Akamatsu
- Department of Gastroenterology, Higashiosaka City Medical Center
| | - Ichizo Kobayashi
- Department of Gastroenterology, Higashiosaka City Medical Center
| | - Masahiko Tsujii
- Department of Gastroenterology, Higashiosaka City Medical Center
| |
Collapse
|
2
|
Tominaga S, Iede K, Chihara T, Yamauchi A. PD3-2-3 The short-time results of the OncoGuide NCC Oncopanel System for use in cancer genome profiling at a single institute. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.05.556] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
3
|
Shobatake R, Ota H, Itaya-Hironaka A, Yamauchi A, Makino M, Sakuramoto-Tsuchida S, Uchiyama T, Takahashi N, Ueno S, Sugie K, Takasawa S. Peptide YY (PYY), glucagon-like peptide-1 (GLP-1), and neurotensin (NTS) are up-regulated by intermittent hypoxia in enteroendocrine cells. J Neurol Sci 2019. [DOI: 10.1016/j.jns.2019.10.420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
4
|
Maeshima Y, Takahara S, Yamauchi A, Yamagami K, Sugie T, Yamashiro H, Kato H, Torii M, Takada M, Torii M. Abstract P3-03-21: Usefulness of sentinel lymph node biopsy by indocyanine green fluorescence method for cN0 breast cancer patients. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p3-03-21] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background. Indocyanine green (ICG) fluorescence method (ICG-f) has been recently widely used in sentinel lymph node (SLN) detection. The advantages of ICG-f are no radiation exposure, no limitation to use in high-volume medical centers without radioactive facility, and to confirm lymph flow as a real-time image from outside the body. ICG-f identified an average of 2.3-3.4 SLNs and the detection rate was 99%, compared to 1.7-2 SLNs by RI methods. Long-term observation after SNB using ICG-f has not been reported, including arm lymphedema as the complication of this method.We evaluate the usefulness of SLN biopsy (SNB) for cN0 breast cancer patients from data of multicenter cohort study on long-term results after negative SNB by ICG-f.
Methods. Eleven hundred and thirty-two women were enrolled who had histologically proved clinical stage T1-4, pN0, M0 primary invasive breast cancer with SNB using ICG-f (ICG alone or combination of RI/blue dye method) sparing axillary lymph node dissection from May 2007 to December 2015. This study is retrospective, multicenter cohort study conducted at 6 centers in Japan. Primary endpoint is axillary recurrence rate. We analyzed the correlation with the axillary recurrence and adjuvant systemic therapy, adjuvant radiotherapy, and the clinicopathological characteristics. Secondary endpoint is lymphedema.
Results and Discussion. The median follow-up time was 41 (range 21-117) months, and axillary recurrence was found in 6 patients (0.53%). Five out of 6 patients were not received standard adjuvant systemic therapy or adjuvant radiation therapy after breast conserving surgerybecause of patient's preference or old age. Lymphedema was identified only 4 patients in 632 patients. It is reported that axillary recurrence after SNB was 0.3-1.65%, which was consistent with our result. Lymphedema was not frequent in patients received SNB using ICG-f, because SLNs are removed along with lymphatic ducts in the limited area of axillary adipose tissue.
Conclusion.Axillary recurrence after negative SNB using ICG-f was comparable to RI or blue dye method. It might be important to perform appropriate adjuvant medication or radiation therapy for preventing axillary recurrence after SNB using ICG-f.
Next, ICG-f after neoadjuvant chemotherapy is to be investigated, because itis reported that removing more than 2 SLNs were associated with a lower likelihood of false negative ratio in patients with clinically node-positive disease converted to clinically node-negative after chemotherapy, and ICG-f might overcome this issue.
Citation Format: Maeshima Y, Takahara S, Yamauchi A, Yamagami K, Sugie T, Yamashiro H, Kato H, Torii M, Takada M, Torii M. Usefulness of sentinel lymph node biopsy by indocyanine green fluorescence method for cN0 breast cancer patients [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P3-03-21.
Collapse
Affiliation(s)
- Y Maeshima
- Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital, Osaka, Japan; Shinko Hospital, Kobe, Japan; Kansai Medical University Hospital, Osaka, Japan; Tenri Hospital, Nara, Japan; Kobe City Medical Center General Hospital, Kobe, Japan; Kyoto University Hospital, Kyoto, Japan
| | - S Takahara
- Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital, Osaka, Japan; Shinko Hospital, Kobe, Japan; Kansai Medical University Hospital, Osaka, Japan; Tenri Hospital, Nara, Japan; Kobe City Medical Center General Hospital, Kobe, Japan; Kyoto University Hospital, Kyoto, Japan
| | - A Yamauchi
- Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital, Osaka, Japan; Shinko Hospital, Kobe, Japan; Kansai Medical University Hospital, Osaka, Japan; Tenri Hospital, Nara, Japan; Kobe City Medical Center General Hospital, Kobe, Japan; Kyoto University Hospital, Kyoto, Japan
| | - K Yamagami
- Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital, Osaka, Japan; Shinko Hospital, Kobe, Japan; Kansai Medical University Hospital, Osaka, Japan; Tenri Hospital, Nara, Japan; Kobe City Medical Center General Hospital, Kobe, Japan; Kyoto University Hospital, Kyoto, Japan
| | - T Sugie
- Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital, Osaka, Japan; Shinko Hospital, Kobe, Japan; Kansai Medical University Hospital, Osaka, Japan; Tenri Hospital, Nara, Japan; Kobe City Medical Center General Hospital, Kobe, Japan; Kyoto University Hospital, Kyoto, Japan
| | - H Yamashiro
- Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital, Osaka, Japan; Shinko Hospital, Kobe, Japan; Kansai Medical University Hospital, Osaka, Japan; Tenri Hospital, Nara, Japan; Kobe City Medical Center General Hospital, Kobe, Japan; Kyoto University Hospital, Kyoto, Japan
| | - H Kato
- Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital, Osaka, Japan; Shinko Hospital, Kobe, Japan; Kansai Medical University Hospital, Osaka, Japan; Tenri Hospital, Nara, Japan; Kobe City Medical Center General Hospital, Kobe, Japan; Kyoto University Hospital, Kyoto, Japan
| | - M Torii
- Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital, Osaka, Japan; Shinko Hospital, Kobe, Japan; Kansai Medical University Hospital, Osaka, Japan; Tenri Hospital, Nara, Japan; Kobe City Medical Center General Hospital, Kobe, Japan; Kyoto University Hospital, Kyoto, Japan
| | - M Takada
- Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital, Osaka, Japan; Shinko Hospital, Kobe, Japan; Kansai Medical University Hospital, Osaka, Japan; Tenri Hospital, Nara, Japan; Kobe City Medical Center General Hospital, Kobe, Japan; Kyoto University Hospital, Kyoto, Japan
| | - M Torii
- Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital, Osaka, Japan; Shinko Hospital, Kobe, Japan; Kansai Medical University Hospital, Osaka, Japan; Tenri Hospital, Nara, Japan; Kobe City Medical Center General Hospital, Kobe, Japan; Kyoto University Hospital, Kyoto, Japan
| |
Collapse
|
5
|
Yamamura M, Yamauchi A, Katase N, Katata Y, Tanioka H, Okawaki M, Nagasaka T, Yamaguchi Y. Heat shock protein 90 (HSP90) inhibitor as a candidate treatment option for gastrointestinal stromal tumor with acquired resistance for conventional receptor tyrosine kinase inhibitors. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy299.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
6
|
Tsuyuki S, Yamagami K, Yoshibayashi H, Sugie T, Mizuno Y, Tanaka S, Kato H, Okuno T, Ogura N, Yamashiro H, Takuwa H, Kikawa Y, Hashimoto T, Kato T, Takahara S, Yamauchi A, Inamoto T. Effectiveness of surgical glove compression therapy as a prophylactic method against nab-paclitaxel induced peripheral neuropathy. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy300.117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
7
|
Maeshima Y, Oobayashi A, Katsuragi R, Yoshimoto Y, Takahara S, Yamauchi A. The possibility of omitting axillary clearance by using indocyanine green fluorescence method in detection of sentinel lymph nodes in early-stage breast cancer. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx655.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
8
|
Shobatake R, Takasawa K, Ota H, Itaya-Hironaka A, Yamauchi A, Sakuramoto-Tsuchida S, Uchiyama T, Makino M, Sugie K, Takasawa S, Ueno S. Intermittent hypoxia up-regulates POMC and cart mRNAs in human neuronal cells. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.846] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
9
|
Sumi-Akamaru H, Eto M, Yamauchi A, Uehara T, Kakuda K, Obayashi K, Kato S, Naka T, Mochizuki H. Evidence that glial cells attenuate G47R transthyretin accumulation in the central nervous system. Neuropathology 2017; 38:11-21. [PMID: 28960480 DOI: 10.1111/neup.12412] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2017] [Revised: 08/03/2017] [Accepted: 08/03/2017] [Indexed: 11/29/2022]
Abstract
Amyloidogenic protein forms amyloid aggregations at membranes leading to dysfunction of amyloid clearance and amyloidosis. Glial cells function in the clearance and degradation of amyloid β (Aβ) in the brain. This study aimed to clarify the reason why amyloid transthyretin (ATTR) rarely accumulates in the CNS. We pathologically analyzed the relationship between amyloid deposition with basement membranes or glial cells in a rare case of ATTR leptomeningeal amyloidosis. In addition, we compared the cytotoxicity of ATTR G47R, the amyloidosis-causing mutation in the case studied (n = 1), and Aβ in brains from patients with cerebral amyloid angiopathy (n = 6). In the subarachnoid space of the ATTR G47R case, most amyloids accumulated at the components of basement membranes. On the CNS surface, ATTR accumulations were retained by astrocytic end feet. In areas where glial end feet enveloped ATTR, ubiquitination and micro-vacuolation of ATTR was evident. The colocalization of GFAP and ubiquitin was also evident. The accumulation of ATTR G47R in the CNS was negatively correlated with the prevalence of astrocytes. Quantitatively, amyloid deposits along the vessels were mostly partial in cerebral Aβ angiopathy cases and nearly complete along the basement membrane in the ATTR G47R case. The vascular expressions of type IV collagen and smooth muscle actin were severely reduced in areas with ATTR G47R deposition, but not in areas with Aβ deposition. The vascular protein level recovered in the ATTR G47R case when vessels entered into areas of parenchyma that were rich in astrocytes. In addition, the strong interactions between the transthyretin variant and basement membranes may have led to dysfunction of transthyretin clearance and leptomeningeal amyloidosis. The present study was the first to show that glial cells may attenuate G47R transthyretin accumulation in the CNS.
Collapse
Affiliation(s)
- Hisae Sumi-Akamaru
- Department of Neurology, Graduate School of Medicine, Osaka University, Suita, Japan
| | - Masaki Eto
- Department of Neurology, Higashiosaka City Medical Center, Higashi-Osaka, Japan
| | - Amane Yamauchi
- Department of Diagnostic Pathology, Higashiosaka City Medical Center, Higashi-Osaka, Japan
| | - Takuya Uehara
- Department of Neurology, Graduate School of Medicine, Osaka University, Suita, Japan.,Department of Neurology, Higashiosaka City Medical Center, Higashi-Osaka, Japan
| | - Keita Kakuda
- Department of Neurology, Graduate School of Medicine, Osaka University, Suita, Japan.,Department of Neurology, Higashiosaka City Medical Center, Higashi-Osaka, Japan
| | - Konen Obayashi
- Department of Morphological and Physiological Sciences, Graduate School of Health Sciences, Kumamoto University, Kumamoto, Japan
| | - Shinsuke Kato
- Division of Neuropathology, Department of Pathology, Tottori University Faculty of Medicine, Yonago, Japan
| | - Takashi Naka
- Department of Neurology, Higashiosaka City Medical Center, Higashi-Osaka, Japan
| | - Hideki Mochizuki
- Department of Neurology, Graduate School of Medicine, Osaka University, Suita, Japan
| |
Collapse
|
10
|
Tsuyuki S, Senda N, Kanng Y, Yamaguchi A, Yoshibayashi H, Kikawa Y, Katakami N, Kato H, Hashimoto T, Okuno T, Yamauchi A, Inamoto T. Abstract PD4-08: Efficacy of compression therapy using surgical gloves for nanoparticle albumin-bound-paclitaxel-induced peripheral neuropathy: A phase II multicenter study by the Kamigata breast cancer study group. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-pd4-08] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
PURPOSE: Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse effect of many commonly used chemotherapeutic agents, including taxanes. However, there is currently no established effective prophylactic management for CIPN. Thus, we investigated the efficacy of using surgical glove (SG) compression therapy to prevent nanoparticle albumin-bound-paclitaxel (nab-PTX)-induced peripheral neuropathy.
PATIENTS AND METHODS: Patients with primary and recurrent breast cancer who received 260 mg/m2 of nab-PTX were eligible for this case-control study. The patients wore two SGs of the same size, that is, one size smaller than the size that fit, on their dominant hand for 90 minutes. They did not wear SGs on the non-dominant hand, which served as the control hand. Peripheral neuropathy was evaluated at each treatment cycle using Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 and the Patient Neurotoxicity Questionnaire (PNQ). The temperatures of each fingertip of the compression SG-protected and control hands were measured by using thermography.
RESULTS: Between August 2013 and January 2016, 43 patients were enrolled, and 42 were evaluated. As shown in Table 1, the overall occurrence of ≥grade 2 sensory and motor peripheral neuropathy according to the CTCAE was significantly lower in the SG-protected hands than in the control hands (76.1% vs. 21.4% and 57.1% vs. 26.2%, respectively, p < 0.0001). The PNQ results showed that the incidence of ≥grade 4 neuropathy was significantly higher in the control hands than in the SG-protected hands in terms of both sensory and motor neurotoxicity (p < 0.0001, Table 2). As the treatment cycles of nab-PTX increased, the mean CTCAE and PNQ grades of the control hands gradually increased. However, the SG-protected hands maintained significantly lower mean grades than the control hands over time (p < 0.0001).
No patients withdrew from this study because they could not tolerate the compression from the SGs. The mean temperature of each fingertip significantly decreased (1.42–2.60 °C) in the SG-protected hands compared to in the control hands.
CONCLUSIONS: SG compression therapy appears effective for reducing nab-PTX-induced peripheral neuropathy. The nab-PTX exposure to the peripheral nerve may be decreased because the SG decreases microvascular flow to the fingertip.
Table 1: Comparison of the overall occurrences of the different grades of peripheral neuropathy according to CTCAE version 4.0 between the compression surgical glove-protected hands and control handsCTCAE v.4.0SensoryMotorGradeSurgical GloveControlSurgical GloveControl012418712161311292411163080840000
Table 2: Changes in the overall occurrence of the Patient Neurotoxicity Questionnaire (PNQ) grade with surgical glove compression therapyPNQSensoryMotorGradeSurgical gloveControlSurgical gloveControl194209223512113717912431611050000
Citation Format: Tsuyuki S, Senda N, Kanng Y, Yamaguchi A, Yoshibayashi H, Kikawa Y, Katakami N, Kato H, Hashimoto T, Okuno T, Yamauchi A, Inamoto T. Efficacy of compression therapy using surgical gloves for nanoparticle albumin-bound-paclitaxel-induced peripheral neuropathy: A phase II multicenter study by the Kamigata breast cancer study group [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr PD4-08.
Collapse
Affiliation(s)
- S Tsuyuki
- OsakaRed Cross Hospital, Osaka, Japan; Kyoto University, Graduate School of Medicine, Kyoto, Japan; Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan; Kobe City Medical Center West Hospital, Kyobe, Hyogo, Japan; Institute of Biomedical Research and Innovation Hospital, Kobe, Hyogo, Japan; Kobe City Medical Center Central Hospital, Kobe, Hyogo, Japan; Hashimoto Clinic, Kobe, Hyogo, Japan; Nishi-Kobe Medical Center, Kobe, Hyogo, Japan; Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan; Tenri Health Care University, Tenri, Nara, Japan
| | - N Senda
- OsakaRed Cross Hospital, Osaka, Japan; Kyoto University, Graduate School of Medicine, Kyoto, Japan; Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan; Kobe City Medical Center West Hospital, Kyobe, Hyogo, Japan; Institute of Biomedical Research and Innovation Hospital, Kobe, Hyogo, Japan; Kobe City Medical Center Central Hospital, Kobe, Hyogo, Japan; Hashimoto Clinic, Kobe, Hyogo, Japan; Nishi-Kobe Medical Center, Kobe, Hyogo, Japan; Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan; Tenri Health Care University, Tenri, Nara, Japan
| | - Y Kanng
- OsakaRed Cross Hospital, Osaka, Japan; Kyoto University, Graduate School of Medicine, Kyoto, Japan; Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan; Kobe City Medical Center West Hospital, Kyobe, Hyogo, Japan; Institute of Biomedical Research and Innovation Hospital, Kobe, Hyogo, Japan; Kobe City Medical Center Central Hospital, Kobe, Hyogo, Japan; Hashimoto Clinic, Kobe, Hyogo, Japan; Nishi-Kobe Medical Center, Kobe, Hyogo, Japan; Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan; Tenri Health Care University, Tenri, Nara, Japan
| | - A Yamaguchi
- OsakaRed Cross Hospital, Osaka, Japan; Kyoto University, Graduate School of Medicine, Kyoto, Japan; Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan; Kobe City Medical Center West Hospital, Kyobe, Hyogo, Japan; Institute of Biomedical Research and Innovation Hospital, Kobe, Hyogo, Japan; Kobe City Medical Center Central Hospital, Kobe, Hyogo, Japan; Hashimoto Clinic, Kobe, Hyogo, Japan; Nishi-Kobe Medical Center, Kobe, Hyogo, Japan; Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan; Tenri Health Care University, Tenri, Nara, Japan
| | - H Yoshibayashi
- OsakaRed Cross Hospital, Osaka, Japan; Kyoto University, Graduate School of Medicine, Kyoto, Japan; Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan; Kobe City Medical Center West Hospital, Kyobe, Hyogo, Japan; Institute of Biomedical Research and Innovation Hospital, Kobe, Hyogo, Japan; Kobe City Medical Center Central Hospital, Kobe, Hyogo, Japan; Hashimoto Clinic, Kobe, Hyogo, Japan; Nishi-Kobe Medical Center, Kobe, Hyogo, Japan; Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan; Tenri Health Care University, Tenri, Nara, Japan
| | - Y Kikawa
- OsakaRed Cross Hospital, Osaka, Japan; Kyoto University, Graduate School of Medicine, Kyoto, Japan; Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan; Kobe City Medical Center West Hospital, Kyobe, Hyogo, Japan; Institute of Biomedical Research and Innovation Hospital, Kobe, Hyogo, Japan; Kobe City Medical Center Central Hospital, Kobe, Hyogo, Japan; Hashimoto Clinic, Kobe, Hyogo, Japan; Nishi-Kobe Medical Center, Kobe, Hyogo, Japan; Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan; Tenri Health Care University, Tenri, Nara, Japan
| | - N Katakami
- OsakaRed Cross Hospital, Osaka, Japan; Kyoto University, Graduate School of Medicine, Kyoto, Japan; Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan; Kobe City Medical Center West Hospital, Kyobe, Hyogo, Japan; Institute of Biomedical Research and Innovation Hospital, Kobe, Hyogo, Japan; Kobe City Medical Center Central Hospital, Kobe, Hyogo, Japan; Hashimoto Clinic, Kobe, Hyogo, Japan; Nishi-Kobe Medical Center, Kobe, Hyogo, Japan; Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan; Tenri Health Care University, Tenri, Nara, Japan
| | - H Kato
- OsakaRed Cross Hospital, Osaka, Japan; Kyoto University, Graduate School of Medicine, Kyoto, Japan; Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan; Kobe City Medical Center West Hospital, Kyobe, Hyogo, Japan; Institute of Biomedical Research and Innovation Hospital, Kobe, Hyogo, Japan; Kobe City Medical Center Central Hospital, Kobe, Hyogo, Japan; Hashimoto Clinic, Kobe, Hyogo, Japan; Nishi-Kobe Medical Center, Kobe, Hyogo, Japan; Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan; Tenri Health Care University, Tenri, Nara, Japan
| | - T Hashimoto
- OsakaRed Cross Hospital, Osaka, Japan; Kyoto University, Graduate School of Medicine, Kyoto, Japan; Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan; Kobe City Medical Center West Hospital, Kyobe, Hyogo, Japan; Institute of Biomedical Research and Innovation Hospital, Kobe, Hyogo, Japan; Kobe City Medical Center Central Hospital, Kobe, Hyogo, Japan; Hashimoto Clinic, Kobe, Hyogo, Japan; Nishi-Kobe Medical Center, Kobe, Hyogo, Japan; Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan; Tenri Health Care University, Tenri, Nara, Japan
| | - T Okuno
- OsakaRed Cross Hospital, Osaka, Japan; Kyoto University, Graduate School of Medicine, Kyoto, Japan; Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan; Kobe City Medical Center West Hospital, Kyobe, Hyogo, Japan; Institute of Biomedical Research and Innovation Hospital, Kobe, Hyogo, Japan; Kobe City Medical Center Central Hospital, Kobe, Hyogo, Japan; Hashimoto Clinic, Kobe, Hyogo, Japan; Nishi-Kobe Medical Center, Kobe, Hyogo, Japan; Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan; Tenri Health Care University, Tenri, Nara, Japan
| | - A Yamauchi
- OsakaRed Cross Hospital, Osaka, Japan; Kyoto University, Graduate School of Medicine, Kyoto, Japan; Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan; Kobe City Medical Center West Hospital, Kyobe, Hyogo, Japan; Institute of Biomedical Research and Innovation Hospital, Kobe, Hyogo, Japan; Kobe City Medical Center Central Hospital, Kobe, Hyogo, Japan; Hashimoto Clinic, Kobe, Hyogo, Japan; Nishi-Kobe Medical Center, Kobe, Hyogo, Japan; Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan; Tenri Health Care University, Tenri, Nara, Japan
| | - T Inamoto
- OsakaRed Cross Hospital, Osaka, Japan; Kyoto University, Graduate School of Medicine, Kyoto, Japan; Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan; Kobe City Medical Center West Hospital, Kyobe, Hyogo, Japan; Institute of Biomedical Research and Innovation Hospital, Kobe, Hyogo, Japan; Kobe City Medical Center Central Hospital, Kobe, Hyogo, Japan; Hashimoto Clinic, Kobe, Hyogo, Japan; Nishi-Kobe Medical Center, Kobe, Hyogo, Japan; Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan; Tenri Health Care University, Tenri, Nara, Japan
| |
Collapse
|
11
|
Ito K, McNamara JM, Yamauchi A, Higginson AD. The evolution of cooperation by negotiation in a noisy world. J Evol Biol 2016; 30:603-615. [PMID: 27987525 DOI: 10.1111/jeb.13030] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/29/2016] [Accepted: 11/29/2016] [Indexed: 01/22/2023]
Abstract
Cooperative interactions among individuals are ubiquitous despite the possibility of exploitation by selfish free riders. One mechanism that may promote cooperation is 'negotiation': individuals altering their behaviour in response to the behaviour of others. Negotiating individuals decide their actions through a recursive process of reciprocal observation, thereby reducing the possibility of free riding. Evolutionary games with response rules have shown that infinitely many forms of the rule can be evolutionarily stable simultaneously, unless there is variation in individual quality. This potentially restricts the conditions under which negotiation could maintain cooperation. Organisms interact with one another in a noisy world in which cooperative effort and the assessment of effort may be subject to error. Here, we show that such noise can make the number of evolutionarily stable rules finite, even without quality variation, and so noise could help maintain cooperative behaviour. We show that the curvature of the benefit function is the key factor determining whether individuals invest more or less as their partner's investment increases, investing less when the benefit to investment has diminishing returns. If the benefits of low investment are very small then behavioural flexibility tends to promote cooperation, because negotiation enables cooperators to reach large benefits. Under some conditions, this leads to a repeating cycle in which cooperative behaviour rises and falls over time, which may explain between-population differences in cooperative behaviour. In other conditions, negotiation leads to extremely high levels of cooperative behaviour, suggesting that behavioural flexibility could facilitate the evolution of eusociality in the absence of high relatedness.
Collapse
Affiliation(s)
- K Ito
- School of Science, Kyushu University, Nishi-ku, Fukuoka, Japan.,Center for Ecological Research, Kyoto University, Otsu, Japan.,Centre for Research in Animal Behaviour, College of Life and Environmental Sciences, University of Exeter, Exeter, UK
| | - J M McNamara
- School of Mathematics, University of Bristol, Bristol, UK
| | - A Yamauchi
- Center for Ecological Research, Kyoto University, Otsu, Japan
| | - A D Higginson
- Centre for Research in Animal Behaviour, College of Life and Environmental Sciences, University of Exeter, Exeter, UK
| |
Collapse
|
12
|
Uehara T, Kakuda K, Sumi-Akamaru H, Yamauchi A, Mochizuki H, Naka T. An autopsy case of leptomeningeal amyloidosis associated with transthyretin Gly47Arg mutation. Rinsho Shinkeigaku 2016; 56:777-780. [PMID: 27784877 DOI: 10.5692/clinicalneurol.cn-000911] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
We report the case of a 47-year-old woman with a 4-year history of progressive numbness in the distal portions of both her lower limbs, diarrhea alternating with periods of constipation, and orthostatic syncope. She demonstrated sensory dominant neuropathy and dysautonomia including orthostatic hypotension, paralytic ileus, and urinary retention. A systemic mutation analysis revealed a G47R mutation in transthyretin (TTR). Her general condition was so poor that we could not perform active treatment. Her consciousness had been impaired for a few months. She died at the age of 47 due to multiple organ failure. An autopsy revealed amyloid deposits in the subarachnoid space of the brainstem and the spinal cord as well as in the peripheral nerve and other organs. To date, this is the first case in which a G47R mutation is associated with leptomeningeal amyloidosis.
Collapse
Affiliation(s)
- Takuya Uehara
- Department of Neurology, Higashiosaka City General Hospital
| | | | | | | | | | | |
Collapse
|
13
|
Ueha R, Nito T, Sakamoto T, Yamauchi A, Tsunoda K, Yamasoba T. Post-operative swallowing in multiple system atrophy. Eur J Neurol 2015; 23:393-400. [PMID: 26518457 DOI: 10.1111/ene.12880] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2015] [Accepted: 08/24/2015] [Indexed: 11/30/2022]
Abstract
BACKGROUND Some patients with multiple system atrophy (MSA) require surgical interventions such as tracheostomy and aspiration prevention. Few studies have investigated the postoperative clinical course of MSA patients. The aim of this study was to determine a management strategy for dysphagia and respiratory disorder in MSA. METHODS From 2001 to 2014, 18 MSA patients (13 males and 5 females, 52-76 years) underwent tracheostomy (TR, n = 11) or laryngeal closure (LC, n = 12). Five patients underwent LC following TR. Vocal fold impairment, the degree of dysphagia and pre/post-operative oral ingestion, and postoperative survival time were evaluated retrospectively. Swallowing function was assessed using the penetration aspiration scale (PAS). RESULTS TR was performed due to respiratory disorder in seven patients and due to dysphagia in four patients. PAS scores ranged 1-8 in TR patients and 7-8 in LC patients. Seven of 11 patients who underwent TR displayed worsened PAS scores, and no patients displayed improved PAS scores following TR. All patients who underwent LC regained complete or partial oral intake after surgery. There were no significant differences in postoperative survival time between the two groups. CONCLUSIONS Considering the impacts of TR and LC on survival time, postoperative feeding and swallowing, LC is a good option for treating MSA patients with dysphagia.
Collapse
Affiliation(s)
- R Ueha
- Department of Otolaryngology, University of Tokyo, Tokyo, Japan
| | - T Nito
- Department of Otolaryngology, University of Tokyo, Tokyo, Japan
| | - T Sakamoto
- Department of Otolaryngology, University of Tokyo, Tokyo, Japan
| | - A Yamauchi
- Department of Otolaryngology, Sanraku Hospital, Tokyo, Japan
| | - K Tsunoda
- Department of Artificial Organs and Otolaryngology, National Institute of Sensory Organs, Tokyo, Japan
| | - T Yamasoba
- Department of Otolaryngology, University of Tokyo, Tokyo, Japan
| |
Collapse
|
14
|
Yamauchi A, Futagami M, Yokoyama Y, Iino K, Shigeto T, Mizunuma H, Kato N, Watanabe J. 2722 The clinicopathological features of relapsed stage IA endometrial cancer. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)31489-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
15
|
Sato Y, Shinka T, Nozawa S, Yoshiike M, Koh E, Kanaya J, Namiki M, Matsumiya K, Tsujimura A, Komatsu K, Itoh N, Eguchi J, Yamauchi A, Iwamoto T, Nakahori Y. Y chromosome haplogroup D2a1 is significantly associated with high levels of luteinizing hormone in Japanese men. Andrology 2015; 3:520-5. [PMID: 25858496 DOI: 10.1111/andr.12026] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2014] [Revised: 02/04/2015] [Accepted: 02/09/2015] [Indexed: 01/12/2023]
Abstract
The association between the Y chromosome haplogroup D2 and risk of azoospermia and low sperm motility has been previously studied, and it was indicated that haplogroups DE (YAP lineage) are associated with prostate cancer risk in Japanese males. Our assumption had been that Y chromosome haplogroups may be associated with sex hormone levels, because sex hormones have been deemed responsible for spermatogenesis and carcinogenesis. In this study, we assessed the association between Y chromosome haplogroups and sex hormone levels, including those of testosterone, sex hormone-binding globulin (SHBG), follicle-stimulating hormone (FSH), luteinizing hormone (LH), inhibin-B, and calculated free testosterone (cFT), in 901 young men from the general Japanese population (cohort 1) and 786 Japanese men of proven fertility (cohort 2). We found that the haplogroup D2a1 was significantly associated with high LH levels in a combined analysis involving two cohorts (β = 0.068, SE = 0.025, p = 0.0075), following correction for multiple testing. To date, this result is the first evidence that implicates Y chromosome haplogroups in an association with sex hormone levels.
Collapse
Affiliation(s)
- Y Sato
- Department of Pharmaceutical Information Science, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan.,Department of Human Genetics and Public Health, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan
| | - T Shinka
- Department of Human Genetics and Public Health, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan
| | - S Nozawa
- Department of Urology, St. Marianna University School of Medicine, Kawasaki, Japan
| | - M Yoshiike
- Department of Urology, St. Marianna University School of Medicine, Kawasaki, Japan
| | - E Koh
- Department of Urology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan
| | - J Kanaya
- Department of Urology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan
| | - M Namiki
- Department of Urology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan
| | - K Matsumiya
- Department of Urology, Osaka Police Hospital, Osaka, Japan
| | - A Tsujimura
- Faculty of Medicine, Department of Urology, Graduate School of Medicine, Osaka University, Osaka, Japan
| | - K Komatsu
- Department of Urology, Harasanshinkai Hospital, Fukuoka, Japan
| | - N Itoh
- Department of Urology, Sapporo Medical University, Sapporo, Japan
| | - J Eguchi
- Department of Urology, Nagasaki University, Nagasaki, Japan
| | - A Yamauchi
- Department of Pharmaceutical Information Science, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan
| | - T Iwamoto
- Department of Urology, St. Marianna University School of Medicine, Kawasaki, Japan.,Center for Infertility and IVF, International University of Health and Welfare Hospital, Nasushiobara, Tochigi, Japan
| | - Y Nakahori
- Department of Human Genetics and Public Health, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan
| |
Collapse
|
16
|
Yamada T, Kim C, Nakagawa T, Hiraoka K, Konishi K, Endo S, Okuyama M, Oda K, Hayakawa M, Yamauchi A, Nishijima J. [Report of a successful case of multidisciplinary therapy for a patient with lung and liver metastasis from rectal adenocarcinoma]. Gan To Kagaku Ryoho 2014; 41:2068-2070. [PMID: 25731425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
A strategy of multidisciplinary therapy is considered necessary for the longer survival of a patient diagnosed with advanced colorectal cancer. We report a successful multi-disciplinary therapy case of a 70's-year-old male who received pulmonary resection for metastatic lung cancer twice after primary resection for rectal cancer. Solitary metastatic liver cancer with portal vein tumor thrombus (PVTT) was diagnosed 5 years and 4 months after primary surgery. Although systemic chemotherapy was started immediately, disease control was poor and local pulmonary recurrence appeared. Although intrahepatic metastasis was considered the most important prognostic factor, radiation therapy against PVTT (50 Gy) was initially performed to control disease. After verifying that no new recurrent lesions had arisen during radiation therapy, a third pulmonary resection (in the left upper remnant lobectomy)was performed. Hepatectomy(in the right lobectomy)was then performed for curative purposes. Pathological efficacy of radiation therapy to PVTT was revealed as GradeIb according to Evans' classification. In accordance with the patient's request, no adjuvant treatment was planned. Seven years after primary resection no sign of recurrence is evident. Radiation therapy is suggested to be most useful for disease control and patient selection.
Collapse
Affiliation(s)
- Terumasa Yamada
- Dept. of Gastroenterological Surgery, Higashiosaka City General Hospital
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Takuwa H, Hagiwara R, Takahara S, Yamauchi A. The Relationship Between Serum E2 Level and Recurrence During Endocrine Therapy for Er Positive Pre-Menopausal Early Breast Cancer Patients. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu327.15] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
18
|
Fujimura T, Fujimoto T, Itaya-Hironaka A, Miyaoka T, Kondo S, Yoshimoto K, Sakuramoto-Tsuchida S, Yamauchi A, Takeda M, Tsujinaka H, Tanaka Y, Takasawa S. AB0189 Interleukin-6/Stat Pathway is Responsible for the Induction of REG Iα, A New Auto-Antigen in SjÖGren's Syndrome Patients, in Salivary Duct Epithelial Cells. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.2813] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
19
|
Proletov I, Sipovskii V, Smirnov A, Hayashi N, Akiyama S, Okuyama H, Matsui Y, Fujimoto K, Atsumi H, Adachi H, Yamaya H, Maruyama S, Imai E, Matsuo S, Yokoyama H, Prasad N, Jaiswal A, Agarwal V, Yadav B, Rai M, Shin DH, Han IM, Moon SJ, Yoo TH, Faria B, Henriques C, Matos AC, Daha MR, Pestana M, Seelen M, Lundberg S, Carlsson MC, Leffler H, Pahlsson P, Segelmark M, Camilla R, Donadio ME, Loiacono E, Peruzzi L, Amore A, Chiale F, Vergano L, Gallo R, Boido A, Conrieri M, Bianciotto M, Bosetti FM, Mengozzi G, Puccinelli MP, Guidi C, Lastauka I, Coppo R, Nishiwaki H, Hasegawa T, Nagayama Y, Komukai D, Kaneshima N, Sasai F, Yoshimura A, Wang CL, Wei XY, Lv L, Jia NY, Vagane AM, Knoop T, Vikse BE, Reisaeter AV, Bjorneklett R, Mezzina N, Brunini F, Trezzi B, Gallieni M, D'Amico M, Stellato T, Santoro D, Ghiggeri GM, Radice A, Sinico RA, Kronbichler A, Kerschbaum J, Mayer G, Rudnicki M, Elena GS, Paula Jara CE, Jorge Enrique RR, Manuel P, Paek J, Hwang E, Park S, Caliskan Y, Aksoy A, Oztop N, Ozluk Y, Artan AS, Yazici H, Kilicaslan I, Sever MS, Yildiz A, Ihara K, Iimori S, Okado T, Rai T, Uchida S, Sasaki S, Stangou M, Bantis C, Skoularopoulou M, Toulkeridis G, Labropoulou I, Kasimatis S, Kouri NM, Papagianni A, Efstratiadis G, Mircescu G, Stancu S, Zugravu A, Petrescu L, Andreiana I, Taran L, Suzuki T, Iyoda M, Yamaguchi Y, Watanabe M, Wada Y, Matsumoto K, Shindo-Hirai Y, Kuno Y, Yamamoto Y, Saito T, Iseri K, Shibata T, Gniewek K, Krajewska M, Jakuszko K, Koscielska-Kasprzak K, Klinger M, Nunes AT, Ferreira I, Neto R, Mariz E, Pereira E, Frazao J, Praca A, Sampaio S, Pestana M, Kim HJ, Lee JE, Proletov I, Galkina O, Bogdanova E, Zubina I, Sipovskii V, Smirnov A, Oliveira CBL, Oliveira ASA, Carvalho CJB, Sette LHBC, Fernandes GV, Cavalcante MA, Valente LM, Ismail G, Andronesi A, Jurubita R, Bobeica R, Finocchietti D, Cantaluppi V, Medica D, Daidola G, Colla L, Besso L, Burdese M, Segoloni GP, Biancone L, Camussi G, Goto S, Nakai K, Ito J, Fujii H, Tasaki K, Suzuki T, Fukami K, Hara S, Nishi S, Hayami N, Ubara Y, Hoshino J, Takaichi K, Suwabe T, Sumida K, Mise K, Wang CL, Tian YQ, Wang H, Saganova E, Proletov I, Galkina O, Bogdanova E, Zubina I, Sipovskii V, Smirnov A, Stancu S, Mandache E, Zugravu A, Petrescu L, Avram A, Mircescu G, Angelini C, Reggiani F, Podesta MA, Cucchiari D, Malesci A, Badalamenti S, Laganovi M, Ars E, ivko M, eljkovic Vrki T, Cori M, Karanovi S, Torra R, Jelakovi B, Jia NY, Wang CL, Zhang YH, Nan L, Nagasawa Y, Yamamoto R, Shinzawa M, Hamahata S, Kida A, Yahiro M, Kuragano T, Shoji T, Hayashi T, Nagatoya K, Yamauchi A, Isaka Y, Nakanishi T, Ivkovic V, Premuzic V, Laganovic M, Dika Z, Kos J, Zeljkovic Vrkic T, Fistrek Prlic M, Zivko M, Jelakovic B, Gigliotti P, Leone F, Lofaro D, Papalia T, Mollica F, Mollica A, Vizza D, Perri A, Bonofilgio R, Meneses G, Viana H, Santos MC, Ferreira C, Calado J, Carvalho F, Remedio F, Nolasco F, Caliskan Y, Oztop N, Aksoy A, Ozluk Y, Artan AS, Turkmen A, Kilicaslan I, Yildiz A, Sever MS, Nagaraju SP, Kosuru S, Parthasarathy R, Bairy M, Prabhu RA, Guddattu V, Koulmane Laxminarayana SL, Oruc A, Gullulu M, Acikgoz E, Aktas N, Yildiz A, Gul B, Premuzic V, Laganovic M, Ivkovic V, Coric M, Zeljkovic Vrkic T, Fodor L, Dika Z, Kos J, Fistrek Prlic M, Zivko M, Jelakovic B, Bale CB, Dighe TA, Kate P, Karnik S, Sajgure A, Sharma A, Korpe J, Jeloka T, Ambekar N, Sadre A, Buch A, Mulay A, Merida E, Huerta A, Gutierrez E, Hernandez E, Sevillano A, Caro J, Cavero T, Morales E, Moreno JA, Praga M. PRIMARY AND SECONDARY GLOMERULONEPHRITIDES 1. Nephrol Dial Transplant 2014. [DOI: 10.1093/ndt/gfu151] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
20
|
Yasojima H, Sugie T, Masuda N, Kinoshita T, Sawada T, Yamauchi A, Kuroi K, Taguchi T, Bando H, Yamashiro H, Lee T, Shinkura N, Kato H, Ikeda T, Yoshimura K, Tada H, Ueyama H, Yokohashi Y, Toi M. Abstract P1-01-03: Interim analysis of the validation study on the clinical usefulness of the ICG fluorescence method for detecting sentinel lymph nodes in early breast cancer compared with the RI method (fICG-BR02). Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p1-01-03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Sentinel lymph node (SLN) biopsy guided by radioisotope (RI), blue dye or in combination methods is common. A high identification rate is reported for the RI-guided method. On the other hand, it has the demerits of radiation exposure, being expense, and it can only be used in a radiation-controlled area. The blue dye method, however, is safe and inexpensive, but the identification rate is lower compared with the RI method and requires training. The indocyanine green (ICG) fluorescent method involves the application of the fluorescing property. Lymph flow can be traced from outside the body with a photodynamic eye (PDE) camera simultaneously with an operation procedure. The ICG method is safe, inexpensive and requires little training, therefore its use will be widely permitted in any general hospitals. Recently, based on several retrospective clinical trials, the identification rate with the ICG fluorescent method has been reported to be equal to or greater than the RI method. The purpose of this multicenter study is to prospectively assess the diagnostic performance of SLN biopsy using the ICG fluorescence technique compared with RI.
Materials and methods: In this validation study, the patients aged from 20 to 75 years-old with operable primary invasive breast cancer (cT1c-2N0M0) have been nominated and required the written informed consent.
All candidates underwent SLN biopsy using the combined methods with RI and ICG fluorescence. The target sample size was 840 patients to evaluate the sensitivity of ICG method as a primary endpoint, and after 200 patients were enrolled we analyzed the identification rate and the SLN-positive rate of the RI and ICG methods respectively as the interim analysis planned beforehand.
Results: Two hundred eligible patients were enrolled in this study from May 2011 to February 2012. Their median age was 53.0 years (range: 27-74 years). The number of patients with cT1c was 106 and that with cT2 was 94. The identification rate of the RI and the ICG method was 97% (194/200) and 96% (192/200) respectively. Of the 194 patients that were identified with the RI method, 186 (95.9%) were also identified with the ICG method. ICG identified 6 patients that were not identified by RI. On the other hand, RI identified 8 patients that were not identified by ICG. The SLN-positive rate was 25.5% (51/200). This rate was higher than we expected. Of the 51 patients with positive metastatic lymph nodes, 23 patients (21.7%) had cT1c breast cancer and 28 (29.8%) had cT2 breast cancer. The positive rate of the first SLN was 23.5% (47/200) and tumor cells skipped to the second or further tier in four cases (2%).
Conclusions: The ICG-guided SLN biopsy procedure achieved a high identification rate almost equal to that with the RI method. Using this combination method, the identification rate was 100%. We will assess the sensitivity and the additive effect of combining the ICG fluorescence method with the RI method, etc., when all 840 patients have been enrolled (UMIN000005167).
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P1-01-03.
Collapse
Affiliation(s)
- H Yasojima
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - T Sugie
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - N Masuda
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - T Kinoshita
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - T Sawada
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - A Yamauchi
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - K Kuroi
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - T Taguchi
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - H Bando
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - H Yamashiro
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - T Lee
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - N Shinkura
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - H Kato
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - T Ikeda
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - K Yoshimura
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - H Tada
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - H Ueyama
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - Y Yokohashi
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| | - M Toi
- National Hospital Organization Osaka National Hospital, Osaka, Japan; Kyoto University Hospital, Kyoto, Japan; National Cancer Center Hospital, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; The Tazuke-Kofukai Medical Research Institute Kitano Hospital, Osaka, Japan; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Tsukuba University Hospital, Tsukuba, Japan; Japanease Red Cross Kyoto Daiichi Hospital, Kyoto, Japan; Kyoto Breast Center Sawai Memorial Clinic, Kyoto, Japan; Kobe City Medical Center General Hospital, Kobe, Japan
| |
Collapse
|
21
|
Yoshimoto K, Fujimoto T, Itaya-Hironaka A, Miyaoka T, Sakuramoto-Tsuchida S, Yamauchi A, Takeda M, Kasai T, Nakagawara K, Nonomura A, Takasawa S. Involvement of autoimmunity to REG, a regeneration factor, in patients with primary Sjögren's syndrome. Clin Exp Immunol 2013; 174:1-9. [PMID: 23701206 DOI: 10.1111/cei.12142] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/16/2013] [Indexed: 12/21/2022] Open
Abstract
The regenerating gene (Reg) was isolated originally as a gene specifically over-expressed in regenerating pancreatic islets and constitute a growth factor family. Reg gene product (Reg) is important in the pathophysiology of various human inflammatory diseases. Recently, the possible involvement of human REG in the regeneration of salivary ductal epithelial cells of patients with primary Sjögren's syndrome (SS) was reported. However, the expression of the REG family genes in minor salivary glands (MSG) and the occurrence of anti-REG Iα autoantibodies in SS patients were obscured. In this study, we examined the expression of REG family genes in the MSG of SS and screened anti-REG Iα autoantibodies in SS. The mRNA levels of REG family genes in MSG were quantified using real-time reverse transcription-polymerase chain reaction (RT-PCR) and REG Iα expression in the MSG was analysed by immunohistochemistry. The mRNA level of REG Iα in the MSG of SS patients was significantly higher than that of control. REG Iα protein was expressed highly in SS ductal epithelial cells. Anti-REG Iα autoantibodies in the sera were found in 11% of SS. All the MSG in the anti-REG Iα autoantibody-positive group showed REG Iα expression, whereas only 40% showed REG Iα expression in the anti-REG Iα autoantibody-negative group. The anti-REG Iα autoantibody-positive group showed significantly lower saliva secretion and a higher ratio of grade 4 (by Rubin-Holt) in sialography. These data suggest strongly that autoimmunity to REG Iα might play a role in the degeneration of MSG ductal epithelial cells in primary SS.
Collapse
Affiliation(s)
- K Yoshimoto
- Department of Biochemistry, Nara Medical University, Kashihara, Japan; Department of General Medicine, Nara Medical University, Kashihara, Japan
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Endo S, Nishikawa K, Yamada T, Nakagawa T, Fushimi H, Chihara T, Yamauchi A, Nishijima J. Our experience of treating undifferentiated gastric carcinoma: report of four cases. Surg Today 2013; 45:235-40. [PMID: 24254063 DOI: 10.1007/s00595-013-0793-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2013] [Accepted: 10/18/2013] [Indexed: 11/29/2022]
Abstract
Undifferentiated gastric carcinoma is a rare histopathological type of cancer that does not show any differentiation toward adenocarcinoma or squamous cell carcinoma. It is thought to be highly malignant, and is associated with a poor prognosis. However, its clinical behavior has not yet been fully analyzed because of its rarity. We herein review the clinical characteristics and prognoses of patients with undifferentiated gastric carcinoma treated at our institutions. Among 2,651 gastric cancer patients, four (0.2 %) were histopathologically diagnosed to have undifferentiated carcinoma. These four patients included three males and one female. The median age of the patients was 60-year old (range 47-75). Three cases had distant metastases at diagnosis. One of these three cases was treated with chemotherapy alone, and the other two were treated with palliative gastrectomy and chemotherapy. The patient with no distant metastasis underwent curative gastrectomy and adjuvant chemotherapy. All patients died of cancer at a median of 5.4 (range 3.5-7.1) months after their diagnoses.
Collapse
Affiliation(s)
- Shunji Endo
- Department of Gastroenterological Surgery, Higashiosaka City General Hospital, 3-4-5 Nishiiwata, Higashiosaka, Osaka, 578-8588, Japan,
| | | | | | | | | | | | | | | |
Collapse
|
23
|
Takuwa H, Oseto K, Hagiwara R, Takahara S, Yamauchi A. The Optimal Treatment for Familial Breast Cancer Patients. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt459.134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
24
|
Inai H, Kawai K, Kojima T, Joraku A, Shimazui T, Yamauchi A, Miyagawa T, Endo T, Fukuhara Y, Miyazaki J, Uchida K, Nishiyama H. Oncological Outcomes of Metastatic Testicular Cancers under Centralized Management through Regional Medical Network. Jpn J Clin Oncol 2013; 43:1249-54. [DOI: 10.1093/jjco/hyt152] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
25
|
Fujimura T, Fujimoto T, Itaya-Hironaka A, Miyaoka T, Yoshimoto K, Sakuramoto-Tsuchida S, Yamauchi A, Tsujinaka H, Tanaka Y, Takasawa S. AB0136 Induction of reg ia, a new auto-antigen in sjögren’s syndrome patients, in salivary duct epithelial cells by interleukin-6 and -11. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.2459] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
26
|
Yoshino T, Yazumi S, Kumagai N, Yamauchi A. Cytomegalovirus colitis in a case of cryptogenic colitis. Endoscopy 2013; 44 Suppl 2 UCTN:E346. [PMID: 23012014 DOI: 10.1055/s-0032-1309915] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/10/2022]
Affiliation(s)
- T Yoshino
- Division of Gastroenterology and Hepatology, Digestive Disease Center, Kitano Hospital, Kitaku, Osaka, Japan
| | | | | | | |
Collapse
|
27
|
Kontani K, Hashimoto S, Murazawa C, Ohtani M, Date M, Yamauchi A, Yokomise H. 1141 Clinical Use of HER2 Extracellular Domain as a Marker to Monitor Cancer Status and Predict the Response to Anti-cancer Treatment in Breast Cancer. Eur J Cancer 2012. [DOI: 10.1016/s0959-8049(12)71737-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
28
|
Miyazaki N, Matsumoto J, Alberici F, Palmisano A, Maritati F, Oliva E, Buzio C, Vaglio A, Mjoen G, Norby GE, Vikse BE, Svarstad E, Rune B, Knut A, Szymczak M, Kuzniar J, Kopec W, Marchewka Z, Klinger M, Arrizabalaga P, Silvarino R, Sant F, Espinosa G, Sole M, Cervera R, Gude D, Chennamsetty S, Demin A, Kozlov V, Lisukov I, Kotova O, Sizikov A, Sergeevicheva V, Demina L, Borjesson O, Wendt M, Avik A, Qureshi AR, Bratt J, Miller EJ, Gunnarsson I, Bruchfeld A, Sugiyama K, Hasegawa M, Yamamoto K, Hayashi H, Koide S, Murakami K, Tomita M, Yoshida S, Yuzawa Y, Yew S, Jayne D, Westman K, Hoglund P, Flossman O, Mahr A, Luqmani R, Robson J, Thervet E, Levi C, Guiard E, Roland M, Nochy D, Daniliuc C, Guillevin L, Mouthon L, Jacquot C, Karras A, Kimura Y, Morita H, Debiec H, Yamada H, Miura N, Banno S, Ronco P, Imai H, Shin DH, Famee D, Koo HM, Han SH, Choi KH, Yoo TH, Kang SW, Fofi C, Fofi C, Scabbia L, Festuccia F, Stoppacciaro A, Mene' P, Shimizu A, Fukui M, MII A, Kaneko T, Masuda Y, Iino Y, Katayama Y, Fukuda Y, Kuroki A, Matsumoto K, Akizawa T, Jurubita R, Ismail G, Bobeica R, Rusu E, Zilisteanu D, Andronesi A, Motoi O, Ditoiu V, Copaci I, Voiculescu M, Irazabal MV, Eirin A, Lieske JC, Beck LH, Dillon JJ, Nachman PH, Sethi S, Erickson SB, Cattran DC, Fervenza FC, Svobodova B, Hruskova Z, Janatkova I, Jancova E, Tesar V, Seo MS, Kwon SH, Lee EB, You JY, Hyun YK, Woo SA, Park MY, Choi SJ, Jeon JS, Noh H, Kim JG, Han DC, Hwang SD, Choi TY, Jin SY, Kwon SH, Loiacono E, Loiacono E, Defedele D, Puccinelli MP, Camilla R, Gallo R, Peruzzi L, Rollino C, Beltrame G, Ferro M, Vergano L, Campolo F, Amore A, Coppo R, Knoop T, Vikse BE, Svarstad E, Bostad L, Leivestad T, Bjorneklett R, Teranishi J, Yamamoto R, Nagasawa Y, Shoji T, Iwatani H, Okada N, Moriyama T, Yamauchi A, Tsubakihara Y, Imai E, Rakugi H, Isaka Y, Koo HM, Doh FM, Kim SJ, Kang SW, Choi KH, Han DS, Han SH, Suzuki Y, Matsuzaki K, Suzuki H, Okazaki K, Yanagawa H, Maiguma M, Muto M, Sato T, Horikoshi S, Novak J, Hotta O, Tomino Y, Gutierrez* E, Zamora I, Ballarin J, Arce Y, Jimenez S, Quereda C, Olea T, Martinez-Ara J, Segarra A, Bernis C, Garcia A, Goicoechea M, Garcia de Vinuesa S, Rojas J, Praga M, Ristovska V, Petrushevska G, Grcevska L, Knoop T, Vikse BE, Svarstad E, Bostad L, Leivestad T, Bjorneklett R, Satake K, Shimizu Y, Mugitani N, Suzuki H, Suzuki Y, Horikoshi S, Honda S, Shibuya K, Shibuya A, Tomino Y, Papale M, Rocchetti MT, DI Paolo S, Suriano IV, D'apollo A, Vocino G, Montemurno E, Varraso L, Grandaliano G, Gesualdo L, Huerta A, Bomback AS, Canetta PA, Radhakrishnan J, Herlitz L, Stokes B, D'agati V, Markowitz G, Appel GB, Ristovska V, Grcevska L, Mouna H, Nasr BD, Mrabet I, Ahmed L, Sabra A, Mohamed Ammeur F, Mezri E, Habib S, Innocenti M, Pasquariello A, Pasquariello G, Mattei P, Bottai A, Fumagalli G, Bozzoli L, Samoni S, Cupisti A, Caldin B, Hung J, Repizo L, Malheiros DM, Barros R, Woronik V, Giammarresi C, Bono L, Ferrantelli A, Tortorici C, Licavoli G, Rotolo U, Huang X, Wang Q, Shi M, Chen W, Liu Z, Scarpioni R, Cantarini L, Lazzaro A, Ricardi M, Albertazzi V, Melfa L, Concesi C, Vallisa D, Cavanna L, Gungor G, Ataseven H, Demir A, Solak Y, Biyik M, Ozturk B, Polat I, Kiyici A, Ozer Cakir O, Polat H, Martinez-Ara J, Castillo I, Carreno V, Aguilar A, Madero R, Hernandez E, Bernis C, Bartolome J, Gea F, Selgas R, El Aggan HAM, El Banawy HS, Wagdy E, Tchebotareva N, LI O, Bobkova I, Kozlovskaya L, Varshavskiy V, Golicina E, Chen Y, Gong Z, Chen X, Tang L, Zhou J, Cao X, Wei R, Koo EH, Koo EH, Park JH, Kim HK, Kim MS, Jang HR, Lee JE, Huh W, Kim DJ, Oh HY, Kim YG, Tchebotareva N, Bobkova I, Kozlovskaya L, LI O, Eskova O, Shvetsov M, Golytsina E, Varshavskiy V, Popova O, Quaglia M, Monti S, Fenoglio R, Menegotto A, Airoldi A, Izzo C, Rizzo MA, Dianzani U, Stratta P, Vaglio A, Vaglio A, Alberici F, Gianfreda D, Buzio C. Primary and secondary glomerulonephritis I. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs223] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
29
|
Valdivia Vega RP, Perez Carlos J, LI X, LI X, Xu X, Zhang W, Ren H, Chen N, Yorioka N, Doi T, Hirashio S, Arita M, Hirabayashi A, Tilkiyan E, Chonova E, Ronchev Y, Kumchev E, Giamalis P, Spartalis M, Stangou M, Tsouchnikas I, Moysiades D, Dimopoulou D, Garyfalos A, Efstratiadis G, Memmos D, Schonermarck U, Eichhorn P, Sitter T, Wendler T, Vielhauer V, Lederer S, Fechner K, Fischereder M, Bantis C, Heering P, Kouri NM, Stangou M, Schwandt C, Kuhr N, Ivens K, Rump LC, Matta V, Melis P, Conti M, Cao R, Binda V, Altieri P, Asunis AM, Catani W, Floris M, Angioi A, Congia M, Cucca F, Minerba L, Peri M, Pani A, Beck LH, Fervenza FC, Fervenza FC, Bomback AS, Ayalon R, Irazabal MV, Eirin A, Cattran DC, Appel GB, Salant DJ, Santoro D, Postorino A, Costantino G, Bellinghieri G, Savica V, Weiner M, Goh SM, Mohammad A, Eriksson P, Westman K, Selga D, Salama A, Segelmark M, Chocova Z, Hruskova Z, Mareckova H, Svobodova B, Jancova E, Bednarova V, Rysava R, Tesar V, Hruskova Z, Jancova E, Hanzal V, Zamboch K, Grussmannova M, Svojanovsky J, Klaboch J, Kubisova M, Sevcik J, Olsanska R, Sobotkova M, Becvar R, Nemec P, Kodeda M, Jilek D, Chocova Z, Tesar V, Hussain M, Dhaygude A, Cartery C, Cartery C, Huart A, Plaisier E, Bongard V, Montastruc F, Ronco P, Pourrat J, Chauveau D, Prasad N, Gurjar D, Bhadauria D, Sharma RK, Gupta A, Kaul A, Jain M, Venning M, Brown N, Bruce I, Noor S, Dhaygude A, Bekker P, Potarca A, Dairaghi D, Miao S, Powers JP, Jaen JC, Schall TJ, Kalavrizioti D, Kalavrizioti D, Gerolymos M, Komninakis D, Rodi M, Mouzaki A, Kalliakmani P, Goumenos D, Choi BS, Choi BS, Park CW, Kim YS, Yang CW, Sun IO, Qin W, Xie L, Tan C, Qin W, Mian W, Fu P, Tan C, Kaminskyy V, Bantis C, Heering P, Kouri NM, Kuhr N, Schwandt C, Ivens K, Rump LC, Hao X, Hao X, Ren H, Wang W, Chen N, Cengiz C, Nur C, Nurdan Y, Selman G, Pinar T, Mehmet T, Lale S, Caliskan S, Shinzawa M, Yamamoto R, Nagasawa Y, Oseto S, Mori D, Niihata K, Fukunaga M, Yamauchi A, Tsubakihara Y, Rakugi H, Isaka Y, Chen JS, Lin YF, Lin WY, Shu KH, Chen HH, Wu CJ, Yang CS, Tseng TL, Zaza G, Bernich P, Lupo A, Panizo N, Rivera F, Lopez Gomez JM, Regn SROG, Ceresini G, Vaglio A, Urban ML, Corradi D, Usberti E, Palmisano A, Buzio C, Vaglio A, Zineb H, Ramdani B, Marques LPJ, Rioja LDS, Rocco R, Nery ACF, Novaes BC, Bridoux F, Sicard A, Labatut D, Touchard G, Sarkozy C, Vanhille P, Callard P, Essig M, Provot F, Nony A, Ronco P, Karras A, Agustin CP, M Belen HR, Carmen CP, Eliana O, Elisa P, Luis P, Alberto MC, Javier N, Isabel F, Cao R, Conti M, Atzeni A, Fois A, Piras D, Maxia S, Angioi A, Binda V, Melis P, Sau G, Pili G, Floris M, Asunis AM, Porcu M, Derudas D, Angelucci E, Ledda A, La Nasa G, Pani A, Ossareh S, Asgari M, Savaj S, Ataipour Y, Abdi E, Malakoutian T, Rajaa R, Berkchi FZ, Haffane L, Squalli Z, Rouass L, Al Hamany Z, Ezzaitouni F, Benamar L, Bayahya R, Ouzeddoun N, Gao-Yuan H, Yao X, Xin C, Zhen C, Yong-Chun G, Qing-Wen W, Hui-Ping C, Da-XI J, De-Hua G, Wei-Xin H, Zhi-Hong L, Rajaa R, Fatima Zahra B, Laila H, Zoubair S, Rouass L, Al Hamany Z, Ezzaitouni F, Benamar L, Bayahya R, Naima O, Smykal-Jankowiak K, Niemir Z, Polcyn-Adamczak M, Szramka-Pawlak B, Zaba R, Zhang C, Zhang C, Ren H, MA Y, Wang W, Zhang W, Shen P, Chen N, Ouyang Y, Ouyang Y, Pan X, Wang Z, Feng X, Shen P, Ren H, Ni L, Zhang W, Chen N. Primary and secondary glomerulonephritis II. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
30
|
Tchebotareva N, Bobkova I, Kozlovskaya L, Li O, Plaisier E, Terrier B, Lacraz A, Bridoux F, Huart A, Marie I, Launay D, Hummel A, Saint-Martin L, Bonnet F, Belenotti P, Kahn JE, Hinschberger O, Rullier P, Cacoub P, Casian A, Szpirt W, Jayne D, Walsh M, Haris A, Polner K, Aranyi J, Braunitzer H, Meran Z, Kaszas I, Mazanowska O, Koscielska-Kasprzak K, Kaminska D, Penar J, Zabinska M, Dziemianko I, Krajewska M, Klinger M, Marco H, Corica M, Picazo M, Arce Y, Llobet JM, Diaz M, Ballarin J, Kuroki A, Akizawa T, Papasotiriou M, Kalliakmani P, Huang L, Gerolymos M, Goumenos DS, Johnson TS, Ogahara S, Abe Y, Ito K, Watanabe M, Saito T, Saito T, Watanabe M, Ito K, Abe Y, Ogahara S, Nesen A, Topchii I, Semenovylh P, Galchinskaya V, Bantis C, Heering P, Kouri NM, Schwandt C, Rump LC, Ivens K, Nagasawa Y, Iio K, Fukuda S, Date Y, Iwatani H, Yamamoto R, Horii A, Inohara H, Imai E, Ohno H, Rakugi H, Rakugi Y, Sahin OZ, Gibyeli Genek D, Alkan Tasli F, Yavas H, Gurses S, Yeniay P, Uzum A, Ersoy R, Cirit M, Christou D, Molyneux K, Peracha J, Feehally J, Smith AC, Barratt J, Yamamoto R, Nagasawa Y, Shoji T, Katakami N, Ohtoshi K, Hayaishi-Okano R, Yamasaki Y, Yamauchi A, Tsubakihara Y, Imai E, Rakugi H, Isaka Y, Faria B, Vidinha J, Pego C, Garrido J, Lemos S, Lima C, Sorbo G, Lorga E, Sousa T, Yavas HH, Sahin OZ, Ozen KP, Gibyeli Genek D, Ersoy R, Alkan Tasli F, Yucel O, Cirit M, Wada Y, Ogata H, Yamamoto M, Ito H, Kinugasa E, Lundberg S, Lundahl J, Gunnarsson I, Jacobson S, Camilla R, Loiacono E, Dapra V, Morando L, Conrieri M, Bianciotto M, Bosetti FM, Gallo R, Peruzzi L, Amore A, Coppo R, Jeong K, Kim Y, Lee TW, Lee SH, Moon JY, Lee S, Ihm C, Komatsu H, Fujimoto S, Kikuchi M, Sato Y, Kitamura K, Sulikowska B, Johnson R, Grajewska M, Donderski R, Odrowaz-Sypniewska G, Manitius J, Amore A, Camilla R, Morando L, Peruzzi L, Rollino C, Quarello F, Colla L, Segoloni G, Caramello E, Cravero R, Quaglia M, Stratta P, Mazzucco G, Coppo R, Coppo R, Grcevska L, Petrusevska G, Nikolov V, Polenakovic M, Lee KW, Ham YR, Jang WI, Jung JY, Jang DS, Chung S, Choi DE, Na KR, Shin YT, Sulikowska B, Johnson R, Grajewska M, Donderski R, Odrowaz-Sypniewska G, Manitius J, Pasquariello A, Innocenti M, Pasquariello G, Mattei P, Colombini E, Ricchiuti G, Sami N, Cupisti A, Rocchetti MT, Di Paolo S, Tamma G, Lasorsa D, Suriano IV, D'Apollo A, Papale M, Mastrofrancesco L, Grandaliano G, Svelto M, Valenti G, Gesualdo L, Wang C, Li Y, Jia N, Fan J, Vigotti FN, Daidola G, Colla L, Besso L, Segoloni GP, Rocchetti MT, Papale M, Di Paolo S, Vocino G, Suriano IV, D'Apollo A, Grandaliano G, Gesualdo L, Berthoux F, Mohey H, Laurent B, Mariat C, Afiani A, Thibaudin L, Rivera F, Segarra A, Praga M, Vozmediano C, Rivera F, Lopez JM, Hernandez D, Pesickova S, Rysava R, Lenicek M, Potlukova E, Jancova E, Vitek L, Honsova E, Zavada J, Svarcova J, Kalousova M, Trendelenburg M, Tesar V, Li X, Ren H, Zhang W, Pan X, Zhang Q, Chen X, Xu Y, Shen P, Chen N, Hruskova Z, Mareckova H, Svobodova B, Jancova E, Bednarova V, Rysava R, Tesar V, Bobrova L, Kozlovskaya N, Khafizova E, Meteleva N, Shakhnova E, Alsuwaida A, Hussain S, Alghonaim M, AlOudah N, Ullah A, Kfoury H, Lorusso P, Bottai A, Cipollini I, Giorgetti M, Barsotti G, Goplani K, Kaswan K, Gera D, Patel H, Gumber M, Shah P, Vanikar A, Trivedi H, Gluhovschi C, Gluhovschi G, Potencz E, Lazar E, Trandafirescu V, Petrica L, Velciov S, Bozdog G, Bob F, Gadalean F, Vernic C, Cioca D, Bantis C, Heering P, Stangou M, Kouri NM, Schwandt C, Memmos D, Rump LC, Ivens K, Tofik R, Rippe B, Torffvit O, Bakoush O, Silska M, Lipkowska K, Warzywoda A, Soltysiak J, Blumczynski A, Musielak A, Ostalska-Nowicka D, Zachwieja J, Spartalis M, Stangou M, Pliakos K, Oikonomidou D, Pantzaki A, Rizopoulou E, Efstratiadis G, Memmos D, Okino VT, Moyses Neto M, Silva GEB, Vieira Neto O, Romao EA, Coelho EB, Dantas M, Liakou H, Stangou M, Ekonomidou D, Pantzaki A, Patinakis P, Sigounas V, Efstratiadis G, Memmos D, Shvetsov M, Bobkova I, Zheng A, Li O, Chebotareva N, Kamyshova E, Rudenko T, Gelpi R, Navarro I, Ngango L, Poveda R, Goma M, Torras J, Grinyo JM, Fulladosa X, Wang Y, Ivany J, Jardine M, Zhong F, Wang W, Ren H, Xie Y, Huang Q, Chen N, Chiappini MG, Di Girolamo M, Grosso A, Muzi L, Panetta V, Khafizova E, Kozlovskaya N, Bobrova L, Bobkova I, Avdonin P, Gluhovschi C, Gluhovschi G, Potencz E, Lazar E, Trandafirescu V, Petrica L, Velciov S, Bozdog G, Bob F, Gadalean F, Vernic C, Cioca D, Ito M, Kimachi M, Nishio S, Koike T, Choi H, Cho AJ, Jang HR, Lee JE, Huh W, Kim DJ, Oh HY, Kim YG. Clinical Nephrology: primary and secondary glomerulonephritis. Clin Kidney J 2011. [DOI: 10.1093/ndtplus/4.s2.35] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
31
|
Yamauchi A, Iwata H, Ohnishi H, Teramoto T, Kondo N, Seishima M. Interleukin-17 expression in the urticarial rash of familial cold autoinflammatory syndrome: a case report. Br J Dermatol 2010; 163:1351-3. [PMID: 20716212 DOI: 10.1111/j.1365-2133.2010.09978.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
32
|
Ikeda JI, Yamauchi A, Hoshida Y, Okamura S, Hashimoto K, Aozasa K, Morii E. Peripheral T-cell lymphoma developing at ileocolonic anastomosis site after colectomy for adenocarcinoma. Pathol Res Pract 2010; 206:376-8. [PMID: 19836149 DOI: 10.1016/j.prp.2009.08.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/19/2009] [Revised: 08/02/2009] [Accepted: 08/05/2009] [Indexed: 12/23/2022]
Abstract
A 69-year-old man underwent right hemicolectomy for colon cancer in the transverse colon in 2005. Two years after surgery, he was admitted with abdominal pain. Colonoscopy revealed a submucosal tumor of approximately 4 cm in size at the ileocolonic anastomosis site. In the biopsied samples from the anastomosis site, there was diffuse proliferation of large lymphoid cells, which were immunohistochemically positive for CD3 and CD4, but negative for CD8 and CD20. Clonality analysis of T-cell receptor-beta gene rearrangement revealed a single band, indicating monoclonal proliferation of the T- lymphocytes. Epstein-Barr virus in situ hybridization did not reveal any positive signals in any of the tumor cells. Anti-human T-lymphotropic virus-I was negative. Based on these findings, the recurrent tumor was diagnosed as peripheral T-cell lymphoma-unspecified (PTCL-u).
Collapse
Affiliation(s)
- Jun-ichiro Ikeda
- Department of Pathology, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan
| | | | | | | | | | | | | |
Collapse
|
33
|
Kontani K, Hashimoto S, Murazawa C, Norimura S, Yokomise H, Yamauchi A. 1048 Requirement of fully activated dendritic cells for elicitation of potent anti-tumour immune responses in cancer patients with impaired immunity. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)70341-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
34
|
Shizusawa T, Shibayama H, Murata S, Saitoh Y, Sugimoto Y, Matsumura I, Ogawa H, Sugiyama H, Fukuhara S, Hino M, Kanamaru A, Yamauchi A, Aozasa K, Kanakura Y. The expression of anamorsin in diffuse large B cell lymphoma: Possible prognostic biomarker for low IPI patients. Leuk Lymphoma 2009; 49:113-21. [DOI: 10.1080/10428190701713697] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
35
|
Nakamichi I, Shimazu K, Ikeda JI, Yamauchi A, Ishiko J, Mizuki M, Kanakura Y, Aozasa K. Intravascular lymphomatosis initially suspected from uterine cytology: a case report. Acta Cytol 2009; 53:198-200. [PMID: 19365976 DOI: 10.1159/000325125] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
BACKGROUND Because recognizable lesions are often absent, selection of biopsy sites for diagnosis of intravascular large B-cell lymphoma (IVL) is frequently problematic. CASE A 59-year-old woman was admitted with fever and general fatigue. Combined physical and roentgenographic examinations revealed neither lymphadenopathy, hepatosplenomegaly nor mass lesions in other organs. Serum lactate dehydrogenase level was 1412 IU/L. There were no genital symptoms, but uterine cytologic examination revealed large cells distributed in a noncohesive pattern. These cells had a large, irregularly shaped nucleus in which several nucleoli were discernible and showed positive immunoreactivity for leukocyte common antigen. Three months after admission, neurologic symptoms appeared, and magnetic resonance imaging revealed multiple nodular lesions in the brain. Biopsy specimens from the brain lesion showed the proliferation of large lymphoid cells filling the lumina of small vessels and Virchow-Robin's space. Immunohistochemistry revealed that the tumor cells were positive for CD20 and CD79a but negative for CD3, indicative of IVL. CONCLUSION Uterine cytologic and/or histologic examinations could be the choice for diagnosis of IVL, even when genital symptoms are absent.
Collapse
Affiliation(s)
- Itsuko Nakamichi
- Department of Pathology, Osaka University Graduate school of Medicine, Osaka, Japan
| | | | | | | | | | | | | | | |
Collapse
|
36
|
Saito S, Matsumiya G, Fukushima N, Sakaguchi T, Fujita T, Ueno T, Miyagawa S, Yamauchi A, Sawa Y. Successful Treatment of Cardiogenic Shock Caused by Humoral Cardiac Allograft Rejection. Circ J 2009; 73:970-3. [DOI: 10.1253/circj.cj-08-0292] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Shunsuke Saito
- Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine
| | - Goro Matsumiya
- Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine
| | - Norihide Fukushima
- Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine
| | - Taichi Sakaguchi
- Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine
| | - Tomoyuki Fujita
- Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine
| | - Takayoshi Ueno
- Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine
| | - Shuji Miyagawa
- Division of Organ Transplantation, Biomedical Research Center, Osaka University Graduate School of Medicine
| | - Amane Yamauchi
- Department of Pathology, Osaka University Graduate School of Medicine
| | - Yoshiki Sawa
- Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine
| |
Collapse
|
37
|
Ohki M, Katoh O, Yamauchi A, Kishida S, Kumagai Y, Fukuoka H, Tayama N. Hearing Loss in HIV Positive Patients. Int J Infect Dis 2008. [DOI: 10.1016/j.ijid.2008.05.1366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
38
|
Yanagawa H, Terao J, Takeda E, Takaishi Y, Kashiwada Y, Kawazoe K, Fushitani S, Tsuchiya K, Yamauchi A, Sato C, Irahara M, Kagawa S. Present status of clinic for complementary and alternative medicine at university hospitals in Japan; a case of Tokushima University Hospital. Eur J Integr Med 2008. [DOI: 10.1016/j.eujim.2008.08.131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
39
|
Yamauchi A, Ikeda J, Nakamichi I, Kohara M, Fukuhara S, Hino M, Kanakura Y, Ogawa H, Sugiyama H, Kanamaru A, Aozasa K. Diffuse large B-cell lymphoma showing an interfollicular pattern of proliferation: a study of the Osaka Lymphoma Study Group. Histopathology 2008; 52:731-7. [DOI: 10.1111/j.1365-2559.2008.03018.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
40
|
EL Sayed AM, Yamauchi A, Darwish NA, Abd EL-Mageed AA, Halim SF. Water and salt permeability of reinforcement polymer-gel composite membrane. J Appl Polym Sci 2008. [DOI: 10.1002/app.28366] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
41
|
Ikeda JI, Morii E, Yamauchi A, Kohara M, Hashimoto N, Yoshikawa H, Iwasaki M, Aozasa K. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type developing in gonarthritis deformans. J Clin Oncol 2007; 25:4310-2. [PMID: 17878483 DOI: 10.1200/jco.2007.12.7092] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Affiliation(s)
- Jun-ichiro Ikeda
- Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan
| | | | | | | | | | | | | | | |
Collapse
|
42
|
Yamauchi A, Fujita S, Ikeda J, Nakamichi I, Fukuhara S, Hino M, Kanakura Y, Ogawa H, Sugiyama H, Kanamaru A, Aozasa K. Diffuse large B-cell lymphoma in the young in Japan: a study by the Osaka Lymphoma Study Group. Am J Hematol 2007; 82:893-7. [PMID: 17573693 DOI: 10.1002/ajh.20968] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Clinicopathological and immunophenotypical characteristics in 24 patients with diffuse large B-cell lymphoma (DLBCL) under 30 years of age in Osaka, Japan were examined, and the results compared to those of DLBCL patients aged over 40 years in Osaka and of young DLBCL patients in Western countries. The level of LDH and IPI score at initial diagnosis were significantly lower in young than older patients. The sex ratio (M:F) and age range (median) in the young and older groups were 1.18 and 11-30 (24.8) years and 1.59 and 42-87 (62.4) years, respectively. Extranodal presentation was higher in the young group (83.3% versus 60.0%, P < 0.05). Based on immunophenotyping with anti-CD10, bcl-6, and MUM1 antibodies, the cases were categorized as germinal center B-cell (GCB) (CD10+ or CD10-, bcl-6+, MUM1+) or non-GCB phenotype. The frequency of GCB type was significantly lower in the young group than older group (25% vs. 54%, P < 0.05), and much lower than that reported for young patients in Western countries. In situ hybridization revealed one of the young patients to be positive for Epstein-Barr virus (EBV). In the older group, none of 31 cases showed EBV positivity. Three year event-free and overall survival rates of young patients were better than those of the older patients, although not significantly different. DLBCL in the young in Japan is characterized by a much lower frequency of the GCB phenotype compared to that in Western countries.
Collapse
Affiliation(s)
- Amane Yamauchi
- Department of Pathology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Inoue S, Yamauchi A, Tabata A, Yamaguchi T, Araida S. [Type B intramural hematoma rupture]. Kyobu Geka 2007; 60:533-7. [PMID: 17642213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
A 70-year-old male, who had complained sudden chest pain and sweating, was admitted to our hospital and diagnosed as a type B intramural hematoma rupture. Emergency repair was performed with arch replacement and open-stent method. Post-operative recovery was satisfactory and the patient was discharged. A type B intramural hematoma rupture is relatively rare. Trans-esophagial echocardiography is quite useful to detect the aortic lesion and to determine the ideal depth of the stent-graft.
Collapse
Affiliation(s)
- Satomi Inoue
- Department of Cardiovascular and Thoracic Surgery, Hokkaido Prefectural Kitami Hospital, Kitami, Japan
| | | | | | | | | |
Collapse
|
44
|
Uzu T, Harada T, Sakaguchi M, Kanasaki M, Isshiki K, Araki S, Sugiomoto T, Koya D, Haneda M, Kashiwagi A, Yamauchi A. Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases. Nephron Clin Pract 2006; 105:c54-7. [PMID: 17135768 DOI: 10.1159/000097598] [Citation(s) in RCA: 80] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2006] [Accepted: 08/15/2006] [Indexed: 12/18/2022] Open
Abstract
BACKGROUND/AIMS In patients with primary renal diseases the current knowledge of hyperglycemia associated with corticosteroid therapy is limited. We therefore examined the prevalence and risk factors of glucocorticoid-induced diabetes mellitus (DM) in primary renal diseases. METHODS Patients were recruited with primary renal diseases who were started on corticosteroids between April 2002 and June 2005. In patients with DM, an impaired fasting glucose level and/or positive urinary glucose analyses before corticosteroids therapy were excluded. RESULTS During corticosteroid therapy (initial dose: prednisolone 0.75 +/- 0.10 mg/kg/day), DM was newly diagnosed in 17 (40.5%) of 42 patients. All of the 17 patients were diagnosed as having DM by postprandial hyperglycemia at 2 h after lunch, although they had normal fasting blood glucose levels. Age (OR 1.40, 95% CI 1.06-1.84) and body mass index (OR 1.87, 95% CI 1.03-3.38) were determined as independent risk factors for glucocorticoid-induced DM. CONCLUSION Over 40% of patients with primary renal disease developed DM during treatment with corticosteroids. A high age and high body mass index are the independent risk factors for glucocorticoid-induced DM. 24-hour urinary glucose analyses and postprandial plasma glucose are useful for detecting glucocorticoid-induced DM.
Collapse
Affiliation(s)
- T Uzu
- Department of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Tanimura N, Tsukamoto K, Okamatsu M, Mase M, Imada T, Nakamura K, Kubo M, Yamaguchi S, Irishio W, Hayashi M, Nakai T, Yamauchi A, Nishimura M, Imai K. Pathology of fatal highly pathogenic H5N1 avian influenza virus infection in large-billed crows (Corvus macrorhynchos) during the 2004 outbreak in Japan. Vet Pathol 2006; 43:500-9. [PMID: 16846992 DOI: 10.1354/vp.43-4-500] [Citation(s) in RCA: 56] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Highly pathogenic H5N1 avian influenza viruses were isolated in 9 large-billed crows that died in Kyoto and Osaka prefectures in Japan from March to April in 2004. We studied 3 of the 9 crows using standard histologic methods, immunohistochemistry, and virus isolation. The most prominent lesions were gross patchy areas of reddish discoloration in the pancreas. The consistent histologic lesions included severe multifocal necrotizing pancreatitis, focal degeneration and necrosis of neuron and glial cells in the central nervous system, and focal degeneration of cardiac myocytes. All of these tissues contained immunohistochemically positive influenza viral antigens. The virus was isolated from the brain, lung, heart, liver, spleen, and kidney of the crows examined. Thus we concluded that highly pathogenic avian influenza virus was associated with clinical disease, severe pathologic changes, and death in the 3 crows.
Collapse
Affiliation(s)
- N Tanimura
- National Institute of Animal Health, 3-1-5 Kannondai, Tsukuba, Ibaraki 305-0856 (Japan).
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Uzu T, Takeji M, Kanasaki M, Isshiki K, Araki S, Sugiomoto T, Kashiwagi A, Uemura M, Miyoshi S, Yamauchi A. Change in circadian rhythm of blood pressure by bilateral radical nephrectomy and haemodialysis: a case report. J Hum Hypertens 2006; 20:549-50. [PMID: 16625239 DOI: 10.1038/sj.jhh.1002027] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
47
|
Yamauchi A, Kontani K, Kihara M, Yokomise H, Nishi N, Hirashima M. P34 Galectin-9 is a possible prognostic factor withanti-metastatic potential for breast cancer. Breast 2005. [DOI: 10.1016/s0960-9776(05)80073-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
48
|
Tanaka A, Harada R, Muraki S, Yamauchi A, Osawa H. [Prevention of acute exacerbation of interstitial pneumonia in the patients operated for lung cancer]. Kyobu Geka 2005; 58:41-5. [PMID: 15678965] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Abstract
Eight patients with interstitial pneumonia (IP) underwent pulmonary surgery for lung cancer. The first patient died due to postoperative exacerbation, but the subsequent 7 patients had good postoperative course without exacerbation by the following careful management. 1) Avoidance of administration of high concentration of oxygen keeping the PO2 about 100 mmHg during the operation. 2) Short-term administration of low-dose steroid before the operation. 3) Administration of erythromycin, tocopherol acetate, and inhalation of N-acetylcysteine before and after the operation. 4) Long-term drainage of the postoperative thoracic discharge to release the local cytokines. These treatments inhibit secretion of the inflammatory cytokines which influence exacerbation of IP.
Collapse
Affiliation(s)
- Akihiko Tanaka
- Department of Thoracic Surgery, Sapporo City General Hospital, Sapporo, Japan
| | | | | | | | | |
Collapse
|
49
|
Shervani NJ, Takasawa S, Uchigata Y, Akiyama T, Nakagawa K, Noguchi N, Takada H, Takahashi I, Yamauchi A, Ikeda T, Iwamoto Y, Nata K, Okamoto H. Autoantibodies to REG, a beta-cell regeneration factor, in diabetic patients. Eur J Clin Invest 2004; 34:752-8. [PMID: 15530148 DOI: 10.1111/j.1365-2362.2004.01419.x] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
BACKGROUND Regenerating gene (Reg) product, Reg, acts as an autocrine/paracrine growth factor for beta-cell regeneration. The presence of autoimmunity against REG may affect the operative of the regenerative mechanisms in beta cells of Type 1 and Type 2 diabetes patients. We screened sera from Type 1 and Type 2 diabetes subjects for anti-REG autoantibodies, searched for correlations in the general characteristics of the subjects with the presence of anti-REG autoimmunity, and tested the attenuation of REG-induced beta-cell proliferation by the autoanitibodies. MATERIAL AND METHODS We examined the occurrence of anti-REG autoantibodies in patients' sera (265 Type 1, 368 Type 2 diabetes patients, and 75 unrelated control subjects) by Western blot analysis, and evaluated inhibitory effects of the sera on REG-stimulated beta-cell proliferation by a 5'-Bromo-2'-deoxyuridine (BrdU) incorporation assay in vitro. RESULTS Anti-REG autoantibodies were found in 24.9% of Type 1, 14.9% of Type 2 and 2.7% of control subjects (P = 0.0004). There were significant differences between the autoantibody positive and negative groups in the duration of disease in the Type 1 subjects (P = 0.0035), and the age of onset in the Type 2 subjects (P = 0.0274). The patient sera containing anti-REG autoantibodies significantly attenuated the BrdU incorporation by REG (35.6 +/- 4.06% of the control), whereas the nondiabetic sera without anti-REG autoantibodies scarcely reduced the incorporation (88.8 +/- 5.10%). CONCLUSION Anti-REG autoantibodies, which retard beta-cell proliferation in vitro, are found in some diabetic patients. Thus, autoimmunity to REG may be associated with the development/acceleration of diabetes in at least some patients.
Collapse
Affiliation(s)
- N J Shervani
- Department of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Tanaka A, Harada R, Muraki S, Yamauchi A, Osawa H. [Removal of the intrapleural hematoma after extrapleural pneumonectomy]. Kyobu Geka 2004; 57:1055-8. [PMID: 15510821] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Abstract
Three cases of pleuropneumonectomy, which have been performed in our institution between 1996 and 2003, are studied. All of them received re-thoracotomy to remove intrapleural hematoma for prolonged high fever, anemia and high level of CRP. Post re-operative courses were satisfactory without any signs of infection. The residual intrapleural hematoma sometimes causes pyothorax and would be an obstacle to the intrapleural instillation of anticancer medications. The removal of the hematoma should be scheduled at an early period after the pleuropneumonectomy.
Collapse
Affiliation(s)
- Akihiko Tanaka
- Department of Thoracic Surgery, Sapporo City General Hospital, Sapporo, Japan
| | | | | | | | | |
Collapse
|